Compound Detail

CHEMBL4472393

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

O=C1/C(=C/c2cccnc2)CN(S(=O)(=O)c2ccccc2)C/C1=C\c1ccccc1F

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4472393
Phase	Preclinical
Structure Type	MOL
InChI Key	ODQNLWTUZAATHZ-KVVJQUGZSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

434.5

MW (Da)

3.96

ALogP

HBA

HBD

67.3

PSA (Å²)

0.58

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 5.32

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
QGY-7703 CHEMBL4296490	IC50	5.32	5.32	4800.0	1
HepG2 CHEMBL395	IC50	5.09	5.09	8210.0	1
Unchecked CHEMBL612545	IC50	4.85	4.85	13990.0	1
L02 CHEMBL4296457	IC50	4.82	4.82	15280.0	1
SMMC-7721 CHEMBL613831	IC50	4.72	4.72	19100.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
QGY-7703	IC50	=	4800.0	nM	5.32	Cytotoxicity against human QGY7703 cells assessed as reduction in cell viability...	30771605
HepG2	IC50	=	8210.0	nM	5.09	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i...	30771605
Unchecked	IC50	=	13990.0	nM	4.85	Cytotoxicity against human HHL5 cells assessed as reduction in cell viability in...	30771605
L02	IC50	=	15280.0	nM	4.82	Cytotoxicity against human LO2 cells assessed as reduction in cell viability inc...	30771605
SMMC-7721	IC50	=	19100.0	nM	4.72	Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viabilit...	30771605

PubMed	DOI	Target Context	# Activities
30771605	10.1016/j.ejmech.2019.02.020	RAW264.7	3
30771605	10.1016/j.ejmech.2019.02.020	HepG2	1
30771605	10.1016/j.ejmech.2019.02.020	QGY-7703	1
30771605	10.1016/j.ejmech.2019.02.020	SMMC-7721	1
30771605	10.1016/j.ejmech.2019.02.020	Unchecked	1
30771605	10.1016/j.ejmech.2019.02.020	L02	1

Data from ChEMBL 36 via Core Engine